6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
Just now	Appendix 4C and Quarterly Activities Report - March 2026
21m ago	Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
21m ago	ING completes share buyback and announces new programme of up to €1.0 billion
22m ago	argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

About

Minerva Neurosciences Inc (NASDAQ:NERV) — investor relations, events, news, and company updates on 6ix.

Latest News

Minerva Announces Leadership Transition

Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia

Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026

Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates

Financials

Revenue

$0

Market Cap

$228.49 M

EPS

-34.67

Community Chat

Ask AI